Correlation between long-term stability of solid lipid nanoparticles (SLN™) and crystallinity of the lipid phase

被引:380
作者
Freitas, C [1 ]
Müller, RH [1 ]
机构
[1] Free Univ Berlin, Dept Pharmaceut Biopharmaceut & Biotechnol, D-12196 Berlin, Germany
关键词
solid lipid nanoparticles; long-term stability; differential scanning calorimetry; polymorphism;
D O I
10.1016/S0939-6411(98)00074-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aqueous dispersions of solid lipid nanoparticles (SLN(TM)) are usually physically stable for more than 3 years. However, in some systems gelation occurred leading to solid gels due to an unknown mechanism. To elucidate this mechanism, Compritol(R) SLN were stored at different temperatures, varying light exposure, in different packing materials and stressed by shear forces in short-term tests and a long-term study of 3 years. The SLN were analyzed by differential scanning calorimetry and sizing techniques. After production by hot homogenization of the melted lipid, the Compritol(R) SLN crystallize in a mixture of stable beta' with unstable polymorphs (alpha, sub alpha). The destabilizing factors light, temperature and shear forces cause a distinct increase in the recrystallization index by transformation of the lipid to the beta' modification being accompanied by gel formation. Physically stable SLN remain as a mixture of modifications, increase in crystallinity index during storage is slow and crystallization occurs mainly in unstable modifications. From this, stabilization of physically critical SLN dispersions seems possible by inhibition of the transformation of the lipid to the stable modification. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:125 / 132
页数:8
相关论文
共 19 条
  • [1] FREITAS C, THESIS FREIE U BERLI
  • [2] FREITAS C, 1998, IN PRESS INT J PHARM
  • [3] Garti N., 1988, CRYSTALLIZATION POLY, P267
  • [4] Hagemann JW, 1988, CRYSTALLIZATION POLY
  • [5] Hemqvist L, 1988, CRYSTALLIZATION POLY, P97
  • [6] HUNTER RJ, 1987, FDN COLLOID SCI, V1, P228
  • [7] JENNIG V, THESIS FREIE U BERLI
  • [8] MULLER BW, 1989, SUPPOSITORIEN
  • [9] MULLER RH, 1995, EUR J PHARM BIOPHARM, V41, P62
  • [10] Muller RH, 1996, APV PAPERBACK SERIES, V37